ClinicalTrials.Veeva

Menu

Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder

Henry Ford Health logo

Henry Ford Health

Status

Completed

Conditions

Shift Work Sleep Disorder

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00688142
C10953/6079/ES/US

Details and patient eligibility

About

The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fundamental mechanisms of attention.

Full description

The current protocol will utilize a paradigm which is well suited to examine frontal attentional neuronal mechanisms by eliciting event related potential components known to reflect automatic stimulus detection as well as involuntary and voluntary attentional processes. The that end the proposed research has two specific aims. 1) Identify what areas of the frontal lobe and corresponding cognitive functions are impacted by excessive sleepiness in shift work sleep disorder and 2) identify specific brain areas affected by armodafinil and their role in improvement of fundamental attentional processes using a complex cognitive task targeting attentional control.

Enrollment

24 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Night shift workers with and without shift work sleep disorder.

Exclusion criteria

  • Secondary condition to shift work sleep disorder.

Trial design

24 participants in 2 patient groups

1
Description:
Individuals with shift work sleep disorder
2
Description:
Healthy night shift workers without shift work sleep disorder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems